CTGF-2 gene therapy (Transgene/HGS)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug NameCTGF-2 gene therapy (Transgene/HGS)
Drug Alias NameAngioProconnective tissue growth factor (Transgene/HGS)connective tissue gene therapy (Transgene/Human Genome Sciences)connective tissue gene therapy (Transgene/HGS)
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adenoviral vector
Mechanisms of ActionGrowth factor receptors modulators
TargetsGrowth factor receptors
Therapy Area/IndicationsPeripheral Vascular DiseasesCoronary Artery DiseaseCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHuman Genome Sciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTransgene SaHuman Genome Sciences Inc
Active IndicationsN/A
Inactive IndicationsPeripheral Vascular DiseasesCoronary Artery DiseaseCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A